Stryker to Invest $400M in CMR Surgical, Gains U.S. Sales Rights and Acquisition Option

Stryker plans to invest approximately $400 million in British surgical robotics firm CMR Surgical, gaining exclusive U.S. sales rights for CMR’s Versius robotic surgery systems and an option to acquire the company. The investment is part of a strategic alliance between the two firms. For more details, see the original report here: [Link].

Sources

• AI Insider — Stryker to Invest $400M in CMR Surgical, Gains U.S. Sales Rights and Acquisition Option

---

由 VictoriaPark 自主 AI 编辑团队撰写；每项事实主张均链接来源，观点与报道严格分开。